Longevity Health Holdings, Inc. (XAGE)
OTCMKTS · Delayed Price · Currency is USD
0.2221
0.00 (0.00%)
At close: Aug 20, 2026
Longevity Health Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1.69 | 1.91 | 0.05 | - | - | - | |
Revenue Growth | 60.33% | 3701.44% | 2.56% | - | - | - |
Cost of Revenue | 0.58 | 0.47 | 0.01 | - | - | - |
Gross Profit | 1.11 | 1.44 | 0.04 | - | - | - |
Selling, General & Admin | 6.24 | 7.33 | 3.9 | 2.62 | 3.22 | 0.86 |
Research & Development | 0.49 | 0.79 | 1.05 | 2.5 | 2.2 | 0.98 |
Operating Expenses | 6.79 | 8.2 | 5.04 | 5.22 | 5.51 | 1.94 |
Operating Income | -5.68 | -6.76 | -5 | -5.22 | -5.51 | -1.94 |
Interest Expense | -0.02 | -0.02 | -0.05 | -0.89 | -3.75 | -2.5 |
Other Non Operating Income (Expenses) | 0.16 | 0.17 | -5.66 | -9.37 | 1.27 | -2.48 |
EBT Excluding Unusual Items | -5.54 | -6.61 | -10.7 | -15.48 | -7.99 | -6.92 |
Merger & Restructuring Charges | -0.41 | -0.41 | - | -0.73 | - | - |
Other Unusual Items | 0.33 | 0.15 | -0.04 | - | -1.06 | 0.44 |
Pretax Income | -6.79 | -6.87 | -10.75 | -16.21 | -9.05 | -6.48 |
Income Tax Expense | 0.04 | 0.04 | -0.1 | - | - | - |
Earnings From Continuing Operations | -6.83 | -6.91 | -10.65 | -16.21 | -9.05 | -6.48 |
Earnings From Discontinued Operations | - | - | 0.28 | 0.76 | - | - |
Net Income to Company | - | -6.91 | -10.37 | -15.45 | -9.05 | -6.48 |
Net Income | -6.83 | -6.91 | -10.37 | -15.45 | -9.05 | -6.48 |
Preferred Dividends & Other Adjustments | - | - | - | 0.68 | 0.56 | 0.31 |
Net Income to Common | -6.83 | -6.91 | -10.37 | -16.12 | -9.61 | -6.79 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 2 | 1 | 1 | 0 | 0 | 1 |
Shares Outstanding (Diluted) | 2 | 1 | 1 | 0 | 0 | 1 |
Shares Change | 119.55% | 100.75% | 93.83% | 527.33% | -92.41% | - |
EPS (Basic) | -3.46 | -4.83 | -14.56 | -43.88 | -164.07 | -8.80 |
EPS (Diluted) | -3.46 | -4.83 | -14.56 | -43.88 | -164.07 | -8.80 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -2.46 | -3.34 | -3.89 | -8.38 | -3.44 | -1.18 |
Free Cash Flow Per Share | -1.25 | -2.34 | -5.47 | -22.81 | -58.67 | -1.53 |
Gross Margin | 65.72% | 75.49% | 87.37% | - | - | - |
Operating Margin | -336.85% | -353.32% | -9933.82% | - | - | - |
Profit Margin | -404.84% | -361.00% | -20605.47% | - | - | - |
Free Cash Flow Margin | -146.06% | -174.79% | -7737.30% | - | - | - |
EBITDA | -5.62 | -6.68 | -4.92 | -5.12 | -5.41 | -1.85 |
D&A For EBITDA | 0.06 | 0.08 | 0.08 | 0.1 | 0.09 | 0.09 |
EBIT | -5.68 | -6.76 | -5 | -5.22 | -5.51 | -1.94 |
Revenue as Reported | 1.69 | 1.91 | 0.05 | - | - | - |